FdaApplication
ANDA 213900
Identifiers
- fda_app_no: ANDA213900
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LIMITED |
| application_type | ANDA |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 50MG | TABLET, EXTENDED RELEASE |
| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 500MG | TABLET, EXTENDED RELEASE |
| CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE |
3 products